Active immunization using a siderophore receptor protein

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S234100, C424S184100, C424S256100, C424S203100, C514S002600

Reexamination Certificate

active

07413743

ABSTRACT:
The invention provides a vaccine for immunizing poultry and other animals against infection by a gram-negative bacteria, and a method of immunizing an animal using the vaccine. The vaccine may contain purified siderophore receptor proteins derived from a single strain or species of gram-negative bacteria or other organism, which are cross-reactive with siderophores produced by two or more strains, species or genera of gram-negative bacteria. The invention further provides a process for isolating and purifying the siderophore receptor proteins, and for preparing a vaccine containing the proteins. Also provided is a method for diagnosing gram-negative sepsis.

REFERENCES:
patent: 4167560 (1979-09-01), Wohler, Jr.
patent: 4452775 (1984-06-01), Kent
patent: 4626416 (1986-12-01), DeVoe et al.
patent: 4663161 (1987-05-01), Mannino et al.
patent: 4681761 (1987-07-01), Mietzner et al.
patent: 4748018 (1988-05-01), Stolle et al.
patent: 4871488 (1989-10-01), Mannino et al.
patent: 4981685 (1991-01-01), Healey
patent: 5141743 (1992-08-01), Schryvers
patent: 5292869 (1994-03-01), Schryvers
patent: 5439808 (1995-08-01), Blake et al.
patent: 5534256 (1996-07-01), Potter et al.
patent: 5538733 (1996-07-01), Emery et al.
patent: 5578314 (1996-11-01), Cochrum et al.
patent: 5587166 (1996-12-01), Donachie
patent: 5688682 (1997-11-01), Mulks et al.
patent: 5830479 (1998-11-01), Emery et al.
patent: 5885589 (1999-03-01), Foged et al.
patent: 5906826 (1999-05-01), Emery et al.
patent: 6027736 (2000-02-01), Emery et al.
patent: 6432412 (2002-08-01), Emery et al.
patent: 6682754 (2004-01-01), Emery et al.
patent: 6720160 (2004-04-01), Wolde-Mariam
patent: 6984503 (2006-01-01), Wang et al.
patent: 7026157 (2006-04-01), Stojilkovic et al.
patent: 7138124 (2006-11-01), Emery et al.
patent: 7138125 (2006-11-01), Emery et al.
patent: 7147857 (2006-12-01), Emery et al.
patent: 7153527 (2006-12-01), Gradle et al.
patent: 7160549 (2007-01-01), Emery et al.
patent: 2003/0036639 (2003-02-01), Emery et al.
patent: 2003/0064073 (2003-04-01), Emery et al.
patent: 2003/0206922 (2003-11-01), Emery et al.
patent: 2003/0211118 (2003-11-01), Emery et al.
patent: 2004/0197350 (2004-10-01), Emery et al.
patent: 2004/0197869 (2004-10-01), Emery et al.
patent: 2004/0265329 (2004-12-01), Emery et al.
patent: 2005/0095682 (2005-05-01), Straub et al.
patent: 2005/0186217 (2005-08-01), Emery et al.
patent: 2006/0083753 (2006-04-01), Emery et al.
patent: 2006/0165718 (2006-07-01), Emery et al.
patent: 2006/0233824 (2006-10-01), Emery et al.
patent: 2006/0269564 (2006-11-01), Emery et al.
patent: 2007/0087011 (2007-04-01), Emery et al.
patent: 2007/0098733 (2007-05-01), Emery et al.
patent: 2029906 (1990-09-01), None
patent: 0 287 206 (1988-10-01), None
patent: WO 90/11349 (1990-10-01), None
patent: WO 90/12591 (1990-11-01), None
patent: WO 95/21627 (1995-08-01), None
patent: WO 96/01620 (1996-01-01), None
patent: WO 01/37810 (2001-05-01), None
patent: WO 01/37810 (2001-05-01), None
Schierack et al. Microbiology 153: 3830-3837, 2007.
Alberti et al., “A porin fromKlebsiells pneumoniae: sequence homology, three-dimensional model, and complement binding,”Infect Immun. Mar. 1995; 63(3): 903-10.
Alurkar et al., “Immunomodulatory Properties of Porins of Some Members of the familyEnterobacteriaceae,” Infection and Immunity, Jun. 1997; 65(6):2382-2388.
Ames, “Resolution of bacterial proteins by polyacrylamide gel electrophoresis on slabs. Membrane, soluble, and periplasmic fractions,”J Biol Chem. Jan. 25, 1974; 249(2):634-44. (No abstract available.).
Anwar et al., “Antibody response to acutePseudomonas aeruginosainfection in a burn wound,”FEMS Microbiology Letters, 1985, 29:225-230.
Arp, “Response of turkeys toEscherichia coli,” Poultry Digest, pp. 142 and 146 (1994).
Ausubel et al., eds.,Current Protocols in Molecular Biology, John Wiley & Sons, Inc., 1998; cover pg., publication pg., and table of contents only (12 pgs).
Babu et al., “Effects of Live Attentuated and KilledSalmonellaVaccine on T-Lymphocyte Mediated Immunity in Laying Hens,”Vet. Immunol. Immunopathol., Jan. 2003, 10; 91(1):39-44.
Banerjee-Bhatnagar et al., “Expression of Neisseria meningitidis iron-regulated outer membrane proteins, including a 70-kilodalton transferrin receptor, and their potential for use as vaccines,”Infect Immun. Sep. 1990; 58(9):2875-81.
Bannerman et al., “The Bovine innate immune repsonse during experimentally-inducedPseudomonas aeruginosamastitis,”Vet. Immunopathol., 2005, 107:210-215.
Bolin et al., “Passive Immunization with Antibodies Against Iron-Regulated Outer Membrane Proteins Protects Turkeys fromEscherichia coliSepticemia”,Infect Immiun., May 1987; 55(5):1239-42.
Boothby et al., “Characterization of antigens from mycoplasms of animal origin,”Am J Vet Res. Mar. 1983; 44(3):433-9.
Bouchet et al., “Immunological variants of the aerobactin-cloacin DF13 outer membrane protein receptor IutA among enteric bacteria,”Infect Immun. Jul. 1994; 62(7):3017-21.
Bradley, “Bovine Mastitis: An Envolving Disease,”Vet. Journal, 2002, 164/2:116-128.
Bragg et al., “Organization of proteins in the native and reformed outer membrane ofEscherichia coli,” Biochim Biophys Acta. Aug. 9, 1972;274(2):478-88. (No abstract available.).
Brogden et al., “Lysates of turkey-grown Pasteurella multocida: effects of solubilizing agents on the immunologic properties of membrane vesicles,”Am J Vet Res. Mar. 1983;44(3):428-32.
Bruckmaier et al., “Changes of physiochemical indicators during mastitis and the effects of milk ejection on their sensitivity,”J. Dairy Res., 2004, 71/3:316-321 (abstract only).
Bruckmaier et al., “Immunomediator and milk protein gene expression in mammry tissue during endotoxin-induced mastitis,”Livestock Production Science, 2005; 98(1/2):81-87, abstract only (1 pg).
Burvenich et al., “Severity ofE. colimastitis is mainly determined by cow factors,”Vet. Res., 2003; 34:521-564.
Calnek et al., Diseases of Poultry—9thed., pp. 99-130, Iowa State University, Ames, Iowa (1991).
CDC National Antimicrobial Resistance Monitoring System: Enteric Bacteria, available at www.cdc.gov
arms/.
CDCSamonellaSurveillance: Annual Summary, 2002. Atlanta, GA: US Department of Health and Human Services, CDC, 2003.
CDCShigellaSurveillance: Annual Summary, 2002. Atlanta, GA: US Department of Health and Human Services, CDC, 2003.
Charles et al., “Adjuvanted Submit Vaccines for the Control of SalmonellaEnteritifisInfection in Turkeys,”Am. J. Vet. Res., May 1994; 55(5):636-642.
Chart et al., “Antigenic and Molecular Homology of the Ferric Enterobactin Receptor Protein ofEscherichia coli”, J. Gen. Microbiol., Jun. 1985; 131(6):1503-9.
Chart et al., “Iron-regulated Outer-membrane Proteins ofEscherichia coliStrains Associated with Enteric or Extraintestinal Diseases of Man and Animals,”J. Gen. Microbio., Jun. 1988; 134(6):1549-1559.
Choi-Kim et al., “Relationship between the iron regulated outer membrane proteins and the outer membrane proteins of in vivo grownPasteurella multocida,” Vet Microbiol. Jun. 1991;28(1):75-92.
Corbett et al., “Effect of Iron Deprivation on Outer Membrane Proteins ofPasteurella multocida,” Abstract, published in the Abstracts of the 85thAnnual Meeting of the American Society for Microbiology, Las Vegas, Nevada, Mar. 3-7, 1985 (13 pgs).
Coulton et al., “Protein II influences ferrichrome-iron transport inEscherichia coliK12,”J Gen Microbiol. Jan. 1979;110(1):211-20.
Courcol et al., “Siderophore production byStaphylococcus aureusand identification of iron-regulated proteins,”Infect. Immun., May 1997; 65(5):1944-8.
Crichton, “Microbial Iron Uptake and Intracellular Release,”Inorganic Biochemistry of Iron Metabolism, Burgess, (ed)., 1991, Ellis Horwood Limited, Chichester, England, 59-76.
Crist et al., &#

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Active immunization using a siderophore receptor protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Active immunization using a siderophore receptor protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Active immunization using a siderophore receptor protein will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4002142

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.